Why the study?
Does the vasopressin V1a receptor mediate salt-induced hypertension in a subtotal nephrectomy mouse model?
Does the vasopressin V1a receptor mediate salt-induced hypertension in a subtotal nephrectomy mouse model?
Answers are grounded in this paper and cite their sources.
The vasopressin V1a receptor mediates salt-induced hypertension, suggesting central V1aR antagonism could be a therapeutic target for hypertension.
AIMS: By examining vasopressin V1a receptor (V1aR) knockout (KO) mice, we previously found that the V1aR is critically involved in the regulation of normal blood pressure. The present study was undertaken to elucidate the role of the V1aR in salt-induced hypertension. METHODS AND RESULTS: We compared haemodynamic responses induced by subtotal nephrectomy + salt loading in V1aR KO mice with those of wild-type (WT) controls. The time course of changes in the systolic blood pressure and heart rate during the salt loading was attenuated in the KO mice compared with that for the WT mice. The elevation of the plasma norepinephrine level caused by the subtotal nephrectomy + salt loading was also reduced in the V1aR KO mice. A V1aR antagonist markedly lowered the arterial blood pressure in the salt-loaded WT mice but not in the normotensive WT mice or in the salt-loaded or normotensive V1aR KO mice. Whereas arginine vasopressin (AVP) administered to the lateral ventricle of the brain induced pressor and tachycardiac responses accompanied by sympathetic activation in the WT mice, these events were completely abolished in the V1aR KO mice. Also, pressor and tachycardiac responses induced by intraventricularly administered hypertonic saline in the WT mice were diminished in the V1aR KO mice. Moreover, the pressor response induced by intraventricularly administered AVP was reduced in alpha(1d) adrenoceptor KO mice, whereas the tachycardiac response did not differ from that of the WT mice. CONCLUSION: These results suggest that the V1aR is involved in the elevation of arterial blood pressure caused by dietary salt and that a V1aR antagonist, in particular regarding its effect in the brain, could have significant therapeutic potential in the treatment of hypertension.
No takes yet. Share an insight, caveat, or question.
Oikawa et al. (2010) studied Salt-induced hypertension. V1aR knockout vs. Wild-type controls was evaluated on Changes in systolic blood pressure and heart rate during salt loading.
Synapse has enriched 10 related papers. Consider them for comparative context: